Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Biotech
Genentech sticks 2nd molecular glue deal with Orionis worth $2B
Roche's Genentech is sticking with Orionis Biosciences, handing over $105 million upfront as part of its second deal with the molecular glue biotech.
James Waldron
May 21, 2025 8:30am
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
Roche's $50B US investment to include upcoming Boston CVRM site
Apr 22, 2025 5:10am
Roche to house its CVRM research work at new Boston hub
Mar 7, 2025 9:40am
Amid political uncertainty, pharmas double down on trial diversity
Feb 27, 2025 8:00am
Genentech archives diversity reports amid site construction
Feb 13, 2025 2:29pm
